凯德尼研究成果再登国际顶刊：AI健康管理应用长期疗效获证实

Research Background and Significance

Chronic kidney disease (CKD) is a global public health challenge affecting approximately 850 million people worldwide. For non-dialysis-dependent chronic kidney disease patients, slowing disease progression and avoiding or delaying dialysis are core treatment goals. However, traditional disease management models face numerous challenges in long-term follow-up and patient compliance.

Breakthrough Research Results

The research paper published in JMIR is titled "Long-Term Efficacy of an AI-Based Health Coaching Mobile App in Slowing the Progression of Nondialysis-Dependent Chronic Kidney Disease: Retrospective Cohort Study".

This represents another significant academic breakthrough for KidneyTec Medical following their 2023 publication in JMIR mHealth and uHealth. This study specifically focuses on the long-term efficacy of the AI health coaching app, further validating the sustained value of digital therapeutics in chronic kidney disease management through extended follow-up observations.

Core Technologies of the KidneyOnline System

The KidneyOnline platform used in the study integrates multiple cutting-edge technologies:

• Intelligent Health Management: Personalized disease management plans based on deep learning
• AI-Assisted Decision Making: Real-time patient health data monitoring with intelligent intervention recommendations
• Precision Nutrition Guidance: Dynamic dietary plan adjustments based on patient conditions
• Comprehensive Health Education: Continuous disease knowledge and self-management guidance through mobile applications
• Doctor-Patient Collaboration Platform: Facilitating ongoing communication between doctors and patients
• Intelligent Early Warning System: Timely detection of condition changes to prevent acute events

Clinical Value of Long-Term Efficacy

The study's key highlight is confirming the sustained long-term efficacy of the AI health coaching app. Research results show that patients using the KidneyOnline platform for disease management demonstrated during long-term follow-up:

• Continuous improvement or stabilization of kidney function indicators
• Significantly slowed disease progression rates
• Sustained improvement in patient self-management capabilities
• Long-term enhancement of quality of life
• Significantly delayed time to dialysis

These findings provide important evidence-based medical evidence for the long-term application value of digital therapeutics in chronic disease management.

Academic Impact and Industry Significance

Journal of Medical Internet Research (JMIR) is an international top-tier journal in medical informatics and digital health, with an impact factor of 5.8, focusing on cutting-edge research in digital health, telemedicine, and health information technology. KidneyTec Medical's ability to publish research results in JMIR and its sub-journals consecutively within two years fully demonstrates the company's research strength and technological innovation capabilities in the digital therapeutics field.

This publication has important industry significance:

• Validated Long-term Value of Digital Therapeutics: Proved that AI health management not only has short-term effects but also sustained long-term clinical benefits
• Provided Basis for Insurance Reimbursement: Long-term efficacy data provides important reference for including digital therapeutics in insurance coverage
• Promoted Establishment of Industry Standards: Provided scientific examples for clinical application and evaluation of digital therapeutics
• Facilitated Healthcare Model Innovation: Demonstrated the application prospects of AI technology in long-term chronic disease management

Future Outlook

The Chief Medical Officer of KidneyTec Medical stated: "This study confirms our core philosophy—through AI-enabled continuous health management, we can truly change the disease trajectory of chronic kidney disease patients. We aim not only to help patients improve short-term indicators but also to achieve substantial delay in disease progression through long-term intervention."

Based on these research findings, KidneyTec Medical will continue to deepen cooperation with medical institutions, conducting larger-scale and longer-term prospective studies to further validate and optimize AI health management solutions. Meanwhile, the company will accelerate the clinical application of digital therapeutics, enabling more chronic kidney disease patients to benefit.

About JMIR

Journal of Medical Internet Research (JMIR), founded in 1999, is one of the most influential academic journals in the global medical informatics and digital health field. The journal focuses on publishing high-quality original research in digital health, telemedicine, mobile health, health information technology, and plays an important role in promoting digital transformation in healthcare.

About KidneyTec Medical

Beijing KidneyTec Medical Technology Co., Ltd. is a leading provider of digital kidney disease management solutions in China, dedicated to improving health management and quality of life for chronic kidney disease patients through advanced technologies such as artificial intelligence and big data. The company's self-developed KidneyOnline platform has served over 1 million chronic kidney disease patients and established deep partnerships with hundreds of medical institutions nationwide.

About the Research Paper

Title: Long-Term Efficacy of an AI-Based Health Coaching Mobile App in Slowing the Progression of Nondialysis-Dependent Chronic Kidney Disease: Retrospective Cohort Study

Journal: Journal of Medical Internet Research (JMIR) (IF: 5.8)

Publication Date: January 2024

Paper Link: https://www.jmir.org/2024/1/e54206